Cagrilintide vs semaglutide Semaglutide is the dominant GLP-1 receptor agonist, with extensive clinical data showing approximately 15-17% body weight reduction at the 2.4 mg weekly dose
If side effects do occur, they are generally mild and may include: Pain, discomfort, swelling, or redness at the injection site Diarrhea Headache Bloating Nausea Numbness or tingling Serious side effects are rare and may include: Confusion Dizziness or fainting Muscle pain, cramps, or weakness Extreme thirst Facial flushing Frequent urination Palpitations Fatigue Difficulty breathing Coughing or noisy breathing (wheezing) Extreme pain, swelling, warmth or tenderness in one leg Difficulty swallowing Rash Itching over the body If you experience serious side effects, contact your doctor right away
Individual results can vary, and factors such as diet, physical activity, starting weight, and medication adherence all play a role
When your system processes toxins effectively, your skin often reflects that internal balance